2017
DOI: 10.1089/ars.2016.6850
|View full text |Cite
|
Sign up to set email alerts
|

Inducible Nitric Oxide Synthase in the Carcinogenesis of Gastrointestinal Cancers

Abstract: Understanding the underlying mechanism involved in NOS2 activation can provide new insights into important prevention and treatment strategies. Antioxid. Redox Signal. 26, 1059-1077.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
54
0
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 67 publications
(57 citation statements)
references
References 185 publications
(179 reference statements)
2
54
0
1
Order By: Relevance
“…Although, the role NO plays in tumors is difficult to predict, the evidence suggests that it depends on the organ of primary tumor [6, 14], stage of disease progression [7, 8] and the types of cancer-associated stromal cells within the TME [16, 20]. Sufficient interest has been generated in developing anticancer drugs that target NO metabolism, but progress towards clinical applications of NOS inhibitors or NO-donors has been limited.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although, the role NO plays in tumors is difficult to predict, the evidence suggests that it depends on the organ of primary tumor [6, 14], stage of disease progression [7, 8] and the types of cancer-associated stromal cells within the TME [16, 20]. Sufficient interest has been generated in developing anticancer drugs that target NO metabolism, but progress towards clinical applications of NOS inhibitors or NO-donors has been limited.…”
Section: Discussionmentioning
confidence: 99%
“…Increase in exogenous NO in the TME is also associated with tumorigenic functions in colon cancer patients. Colon cancer patients with high NOS2 expression have increased incidences of lymph node metastasis; and elevated NOS2 expression observed in the upper colon in colitis patients indicates higher risk of developing colon cancer [7, 8]. In addition to regulating metastasis and tumor initiation, NO is also a key regulator of angiogenesis .…”
Section: No: Modulator Of the Tmementioning
confidence: 99%
“…These include colon, breast, gastric, hepatocellular carcinoma, melanoma, ovarian, leukemia, gastric, prostate, esophageal, and cervical [279, 280]. It has thus been suggested that iNOS expression may be used as a biomarker of poor patient prognosis and perhaps survival [281, 282]. By contrast, favorable prognosis has been associated with high iNOS expression in ovarian (10-year prognosis) [283] and non-small cell lung cancers [284].…”
Section: Modulation Of No Levels As a Strategy To Treat Cancermentioning
confidence: 99%
“…The maintenance of cell redox state is important to cell viability [43]. The increased level of reactive species can lead to oxidative damage to a vast number of biological molecules, as DNA [44][45][46], proteins [47], lipids [48], including membranes [3] leading to a range of pathologies, as cancer [36], neurological disease [49], cardiac disease [50,51], inflammation process [52] and aging.…”
Section: Cellular Respiration and Generation Of Reactive Species In Tmentioning
confidence: 99%
“…Nitric oxide is a membrane permeable free radical that participates in a multiple process in the cells as signaling molecule, but also can contribute in cell oxidative damage. Its effect depends on NO levels and localization in the cell microenvironment [35,36]. When nitric oxide is present in environment, as in mitochondrial matrix, the reaction of this free radical with superoxide can form others RNS, as peroxynitrite.…”
mentioning
confidence: 99%